Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Cardinal Health’s Debbie Weitzman and Value Drug Company’s Rick Seipp to Lead HDA Board Of Directors
The Healthcare Distribution Alliance (HDA) announced today that Debbie Weitzman, chief executive officer, pharmaceutical and specialty solutions, Cardinal Health, was elected chair of the association’s Board of Directors. Rick Seipp, president and chief executive officer of Value Drug Company, will serve as vice chair.
Five Things to Know: Pharmaceutical Distributors and Vaccine Distribution
The successful development of COVID-19 vaccines will mark a groundbreaking step in our fight against the pandemic. However, the massive demand for approved vaccines and therapies as they come to market will require extensive coordination across the pharmaceutical supply chain and with the public sector.
HDA Factbook: Prescription Sales Through Traditional Healthcare Distributors Remain Strong in 2023
New data released by the HDA Research Foundation reveal that total prescription sales through traditional pharmaceutical distributors grew by 13.7 percent in 2023.